Technologies for the Synthesis of mRNA-Encoding Libraries and Discovery of Bioactive Natural Product-Inspired Non-Traditional Macrocyclic Peptides

被引：51

作者：

Ito, Kenichiro ^{[1
]}

Passioura, Toby ^{[1
]}

Suga, Hiroaki ^{[1
]}

机构：

[1] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan

来源：

MOLECULES | 2013年 / 18卷 / 03期

关键词：

non-standard macrocyclic peptides; non-canonical amino acids; flexizyme; Random non-standard Peptide Integration Discovery (RaPID) system; peptide inhibitors; IN-VITRO SELECTION; UNNATURAL AMINO-ACIDS; CYCLIC-PEPTIDES; RIBOSOMAL SYNTHESIS; GENETIC-CODE; TRANSLATION INITIATION; BICYCLIC PEPTIDES; DRUG DISCOVERY; N-METHYLATION; DE-NOVO;

D O I：

10.3390/molecules18033502

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In this review, we discuss emerging technologies for drug discovery, which yields novel molecular scaffolds based on natural product-inspired non-traditional peptides expressed using the translation machinery. Unlike natural products, these technologies allow for constructing mRNA-encoding libraries of macrocyclic peptides containing non-canonical sidechains and N-methyl-modified backbones. The complexity of sequence space in such libraries reaches as high as a trillion (>10(12)), affording initial hits of high affinity ligands against protein targets. Although this article comprehensively covers several related technologies, we discuss in greater detail the technical development and advantages of the Random non-standard Peptide Integration Discovery (RaPID) system, including the recent identification of inhibitors against various therapeutic targets.

引用

页码：3502 / 3528

页数：27

共 85 条

[1] Activation of AKT kinases in cancer: Implications for therapeutic targeting [J].

Bellacosa, A ;

Kumar, CC ;

Di Cristofano, A ;

Testa, JR .

ADVANCES IN CANCER RESEARCH, VOL 94, 2005, 94 :29-+

[2] Improving oral bioavailability of peptides by multiple N-methylation: Somatostatin analogues [J].

Biron, Eric ;

Chatterjee, Jayanta ;

Ovadia, Oded ;

Langenegger, Daniel ;

Brueggen, Joseph ;

Hoyer, Daniel ;

Schmid, Herbert A. ;

Jelinek, Raz ;

Gilon, Chaim ;

Hoffman, Amnon ;

Kessler, Horst .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2008, 47 (14) :2595-2599

[3] Hit and lead generation:: Beyond high-throughput screening [J].

Bleicher, KH ;

Böhm, HJ ;

Müller, K ;

Alanine, AI .

NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :369-378

[4] Getting in Shape: Controlling Peptide Bioactivity and Bioavailability Using Conformational Constraints [J].

Bock, Jonathan E. ;

Gavenonis, Jason ;

Kritzer, Joshua A. .

ACS CHEMICAL BIOLOGY, 2013, 8 (03) :488-499

[5]

BUCHMAN GW, 1988, J BIOL CHEM, V263, P16260

[6]

Cotten SW, 2012, METHODS MOL BIOL, V805, P287, DOI 10.1007/978-1-61779-379-0_16

[7] The exploration of macrocycles for drug discovery - an underexploited structural class [J].

Driggers, Edward M. ;

Hale, Stephen P. ;

Lee, Jinbo ;

Terrett, Nicholas K. .

NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (07) :608-624

[8] RIBOSOME-CATALYZED POLYESTER FORMATION [J].

FAHNESTOCK, S ;

RICH, A .

SCIENCE, 1971, 173 (3994) :340-+

[9] Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: Logic, machinery, and mechanisms [J].

Fischbach, Michael A. ;

Walsh, Christopher T. .

CHEMICAL REVIEWS, 2006, 106 (08) :3468-3496

[10] Programming peptidomimetic syntheses by translating genetic codes designed de novo [J].

Forster, AC ;

Tan, ZP ;

Nalam, MNL ;

Lin, HN ;

Qu, H ;

Cornish, VW ;

Blacklow, SC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) :6353-6357

← 1 2 3 4 5 6 7 8 9 →